Short answer · Medically reviewed summary · Last updated: 2026-05-08
Congenital Hyperinsulinism (CHI) is primarily categorized under the ICD-10 code E16.1 (Other hypoglycemia, including hyperinsulinemic hypoglycemia), while it does not have a unique, dedicated code in the legacy ICD-9 system, often being classified under 251.1 (Other specified hypoglycemia). These codes are used by healthcare providers for administrative and billing purposes to identify the persistent, unregulated insulin secretion characteristic of this rare metabolic disorder. Why are medical codes like ICD-10 important for Congenital Hyperinsulinism? For families managing Congenital Hyperinsulinism, these codes serve as a standardized language for insurance companies, hospitals, and researchers.
Congenital Hyperinsulinism (CHI) is primarily categorized under the ICD-10 code E16.1 (Other hypoglycemia, including hyperinsulinemic hypoglycemia), while it does not have a unique, dedicated code in the legacy ICD-9 system, often being classified under 251.1 (Other specified hypoglycemia). These codes are used by healthcare providers for administrative and billing purposes to identify the persistent, unregulated insulin secretion characteristic of this rare metabolic disorder.
For families managing Congenital Hyperinsulinism, these codes serve as a standardized language for insurance companies, hospitals, and researchers. Because Congenital Hyperinsulinism is a rare disease, accurate coding ensures that clinical data is tracked correctly, which helps in securing coverage for specialized treatments, such as diazoxide or surgical interventions like pancreatectomy.
Diagnosis of Congenital Hyperinsulinism is typically confirmed through a combination of clinical biochemical markers and genetic testing. Physicians look for specific diagnostic criteria during episodes of hypoglycemia, including:
Yes, Congenital Hyperinsulinism often has a genetic basis, with approximately 50% of cases involving mutations in the ABCC8 or KCNJ11 genes. These mutations can be inherited in an autosomal recessive or autosomal dominant pattern, or they may occur as a de novo mutation. Genetic counseling is highly recommended for families to understand the recurrence risks associated with Congenital Hyperinsulinism.
Living with Congenital Hyperinsulinism requires constant vigilance, and connecting with others can provide vital emotional support. Currently, 5 members of the DiseaseMaps community have shared their experiences, offering a unique perspective on navigating the daily challenges of this condition. Sharing resources and personal coping strategies can significantly reduce the isolation often felt by caregivers of children with Congenital Hyperinsulinism.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.